(Q277979)

nalbuphine (English)

3 October 2016

C₂₁H₂₇NO₄

1 reference

nalbuphine (English)

19 November 2016

C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O

1 reference

nalbuphine (English)

19 November 2016

C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O

1 reference

parenteral route of administration

nalbuphine (English)

19 November 2016

80 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N02AF02

World Health Organisation international non-proprietary name

nalbuphine (English)

1 reference

nalbuphine (English)

medical condition treated

3 October 2016

1 reference

physically interacts with

13 December 2016

Opioid receptor delta 1

subject has role

agonist

1 reference

17 August 2016

Opioid receptor, kappa 1

subject has role

agonist

1 reference

17 August 2016

opioid receptor kappa 1

subject has role

agonist

1 reference

17 August 2016

1 reference

InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1

17 August 2016

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Nalbuphine

0 references

Identifiers

InChI

1 reference

nalbuphine (English)

19 November 2016

2 references

nalbuphine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

20594-83-6

2 references

nalbuphine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=20594-83-6

10 April 2021

1 reference

Nalbuphine (English)

19 November 2016

1 reference

nalbuphine (English)

19 November 2016

Reaxys registry number

4566620

1 reference

nalbuphine (English)

3 October 2016

mapping relation type

2 references

NALBUPHINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1

1 reference

NALBUPHINE (English)

19 November 2016

2 references

inferred from InChIKey

1 reference

MassBank accession ID

MSBNK-Waters-WA001514

0 references

MSBNK-Waters-WA001515

0 references

MSBNK-Waters-WA001516

0 references

MSBNK-Waters-WA001517

0 references

MSBNK-Waters-WA001518

0 references

DSSTox substance ID

DTXSID8023345

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

nalbuphine (English)

ECHA Substance Infocard ID

19 November 2016

100.039.895

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Nalbuphine (English)

CAS no.: 20594-83-6 (English)

1 reference

Nalbuphine (English)

publication date

17 November 2015

1 reference

nalbuphine (English)

19 November 2016

Nalbuphine

0 references

0 references

0 references

0 references

0 references

0 references

1 reference

nalbuphine (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014982

2 references

based on heuristic

inferred from InChIKey

2 references

nalbuphine (English)

19 November 2016

MedlinePlus drug identifier

a682668

0 references

PatientsLikeMe treatment ID

0 references

1 reference

nalbuphine (English)

19 November 2016

0 references

1 reference

1 reference

nalbuphine (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

nalbuphine (English)

3 October 2016

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

0 references

1 reference